Experimental models of status epilepticus and neuronal injury for evaluation of therapeutic interventions

International Journal of Molecular Sciences

Volumn 14, Issue 9, 2013, Pages 18284-18318

  Reddy, Doodipala Samba ^a   Kuruba, Ramkumar ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

DFP; Epilepsy; Kainic acid; Neurodegeneration; Perforant stimulation; Pilocarpine; Seizure

Indexed keywords

4 AMINOPYRIDINE; BENZODIAZEPINE DERIVATIVE; CONVULSANT AGENT; CYTOKINE; DIAZEPAM; DYFLOS; FLUROTHYL; FOSPHENYTOIN SODIUM; HOMOCYSTEINE THIOLACTONE; KAINIC ACID; LITHIUM CHLORIDE; LORAZEPAM; MAGNESIUM; MIDAZOLAM; NEURON SPECIFIC NUCLEAR PROTEIN; ORGANOPHOSPHATE PESTICIDE; PARAOXON; PHENOBARBITAL; PHENYTOIN; PILOCARPINE; POTASSIUM; PROPOFOL;

APOPTOSIS; BRAIN SLICE; COGNITIVE DEFECT; DISEASE MODEL; DRUG EFFICACY; DRUG SCREENING; ELECTROSTIMULATION; EPILEPSY; EPILEPTIC DISCHARGE; EPILEPTIC STATE; EPILEPTOGENESIS; EXPERIMENTAL MODEL; FEBRILE CONVULSION; HIPPOCAMPUS; HUMAN; MOSSY FIBER; NERVE CELL LESION; NERVE CELL NECROSIS; NERVE DEGENERATION; NERVE SPROUTING; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NICK END LABELING; NISSL STAINING; NONHUMAN; PERFORANT NERVE TRACT; REVIEW; TEMPORAL LOBE EPILEPSY; TONIC CLONIC SEIZURE;

ANIMALS; CONVULSANTS; ELECTRIC STIMULATION THERAPY; FLUROTHYL; HUMANS; KAINIC ACID; NEURODEGENERATIVE DISEASES; PERFORANT PATHWAY; PILOCARPINE; STATUS EPILEPTICUS;

EID: 84883635697     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140918284     Document Type: Review

References (182)

1. Jacobs, M.P.; Leblanc, G.G.; Brooks-Kayal, A.; Jensen, F.E.; Lowenstein, D.H.; Noebels, J.L.; Noebels, J.L.; Spencer, D.D.; Swann, J.W. Curing epilepsy: Progress and future directions. Epilepsy Behav. 2009, 14, 438-445.
2. Hesdorffer, D.C.; Beck, V.; Begley, C.E.; Bishop, M.L.; Cushner-Weinstein, S.; Holmes, G.L.; Shafer, P.O.; Sirven, J.I.; Austin, J.K. Research implications of the Institute of Medicine Report, Epilepsy Across the Spectrum: Promoting health and understanding. Epilepsia 2013, 54, 207-216.
3. Pitkanen, A.; Immonen, R.J.; Grohn, O.H.; Kharatishvili, I. From traumatic brain injury to posttraumatic epilepsy: What animal models tell us about the process and treatment options. Epilepsia 2009, 50, 21-29.
4. Sutula, T.P. Mechanisms of epilepsy progression: Current theories and perspectives from neuroplasticity in adulthood and development. Epilepsy Res. 2004, 60, 161-171.
5. Dudek, F.E.; Staley, K.J. The time course of acquired epilepsy: Implications for therapeutic intervention to suppress epileptogenesis. Neurosci. Lett. 2011, 497, 240-246.
6. Dudek, F.E.; Bertram, H.; Staley, K.J. Antiepileptogenesis therapy with levetiracetam: Data from kindling versus status epilepticus models. Epilepsy Curr. 2008, 8, 28-30.
7. Pitkänen, A.; Lukasiuk, K. Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurol. 2011, 10, 173-186.
8. Duncan, J.S.; Sander, J.W.; Sisodiya, S.M.; Walker, M.C. Adult epilepsy. Lancet 2006, 367, 1087-1100.
9. Babb, T.L. Synaptic reorganizations in human and rat hippocampal epilepsy. Adv. Neurol. 1999, 79, 763-779.
10. Engel, J., Jr. Clinical neurophysiology, neuroimaging, and the surgical treatment of epilepsy. Curr. Opin. Neurol. Neurosurg. 1993, 6, 240-249.
11. Cendes, F. Progressive hippocampal and extrahippocampal atrophy in drug resistant epilepsy. Curr. Opin. Neurol. 2005, 18, 173-177.
12. Delgado-Escueta, A.V.; Wasterlain, C.; Treiman, D.M.; Porter, R.J. Status epilepticus: Summary. Adv. Neurol. 1983, 34, 537-541.
13. DeLorenzo, R.J.; Towne, A.R.; Pellock, J.M.; Ko, D. Status epilepticus in children, adults, and the elderly. Epilepsia 1992, 33, S15-S25.
14. Lothman, E. The biochemical basis and pathophysiology of status epilepticus. Neurology 1990, 40, 13-23.
15. Knake, S.; Hamer, H.M.; Rosenow, F. Status epilepticus: A critical review. Epilepsy Behav. 2009, 15, 10-14.
16. Brophy, G.M.; Bell, R.; Claassen, J.; Alldredge, B.; Bleck, T.P.; Glauser, T.; Laroche, S.M.; Riviello, J.J., Jr.; Shutter, L.; Sperling, M.R.; et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit. Care 2012, 17, 3-23.
17. Silbergleit, R.; Durkalski, V.; Lowenstein, D.; Conwit, R.; Pancioli, A.; Palesch, Y.; Barsan, W.; NETT Investigators. Intramuscular versus intravenous therapy for prehospital status epilepticus. N. Engl. J. Med. 2012, 366, 591-600.
18. Mayer, S.A.; Claassen, J.; Lokin, J.; Mendelsohn, F.; Dennis, L.J.; Fitzsimmons, B.F. Refractory status epilepticus: Frequency, risk factors, and impact on outcome. Arch. Neurol. 2002, 59, 205-210.
19. Wheless, J.W.; Treiman, D.M. The role of the newer antiepileptic drugs in the treatment of generalized convulsive status epilepticus. Epilepsia 2008, 49, 74-78.
20. Yaffe, K.; Lowenstein, D.H. Prognostic factors of pentobarbital therapy for refractory generalized status epilepticus. Neurology 1993, 43, 895-900.
21. Krishnamurthy, K.B.; Drislane, F.W. Relapse and survival after barbiturate anesthetic treatment of refractory status epilepticus. Epilepsia 1996, 37, 863-867.
22. Stecker, M.M.; Kramer, T.H.; Raps, E.C.; O'Meeghan, R.; Dulaney, E.; Skaar, D.J. Treatment of refractory status epilepticus with propofol: Clinical and pharmacokinetic findings. Epilepsia 1998, 39, 18-26.
23. Claassen, J.; Hirsch, L.J.; Emerson, R.G.; Mayer, S.A. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: A systematic review. Epilepsia 2002, 43, 146-153.
24. Nadler, J.V. Kainic acid: Neurophysiological and neurotoxic actions. Life Sci. 1979, 24, 289-299.
25. Ben-Ari, Y. Limbic seizure and brain damage produced by kainic acid: Mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 1985, 14, 375-403.
26. Clifford, D.B.; Olney, J.W.; Maniotis, A.; Collins, R.C.; Zorumski, C.F. The functional anatomy and pathology of lithium-pilocarpine and high-dose pilocarpine seizures. Neuroscience 1987, 23, 953-968.
27. Turski, W.A.; Cavalheiro, E.A.; Schwarz, M.; Czuczwar, S.J.; Kleinrok, Z.; Turski, L. Limbic seizures produced by pilocarpine in rats: Behavioural, electroencephalographic and neuropathological study. Behav. Brain Res. 1983, 9, 315-335.
28. Sloviter, R.S. Epileptic brain damage in rats induced by sustained electrical stimulation of the perforant path. I. Acute electrophysiological and light microscopic studies. Brain Res. Bull. 1983, 10, 675-697.
29. 2+ sensitivity of hippocampal dentate granule cell GABA-A receptors. J. Neurosci. 1997, 17, 7532-7540.
30. Jones, D.M.; Esmaeil, N.; Maren, S.; Macdonald, R.L. Characterization of pharmacoresistance to benzodiazepine in the rat Li-Pilocarpine model of status epilepticus. Epilepsy Res. 2002, 50, 301-312.
31. Rao, M.S.; Hattiangady, B.; Reddy, D.S.; Shetty A.K. Hippocampal neurodegeneration, spontaneous seizures, and mossy fiber sprouting in the F344 rat model of temporal lobe epilepsy. J. Neurosci. Res. 2006, 83, 1088-1105.
32. Sharma A.K.; Reams, R.Y.; Jordan, W.H.; Miller, M.A.; Thacker, H.L.; Snyder, P.W. Mesial temporal lobe epilepsy: Pathogenesis, induced rodent models and lesions. Toxicol. Pathol. 2007, 35, 984-999.
33. Williams, P.A.; White, A.M.; Clark, S.; Ferraro, D.J.; Swiercz, W.; Staley, K.J.; Dudek, F.E. Development of spontaneous recurrent seizures after kainate-induced status epilepticus. J. Neurosci. 2009, 29, 2103-2112.
34. White, A.; Williams, P.A.; Hellier, J.L.; Clark, S.; Dudek, E.F.; Staley, K.J. EEG spike activity precedes epilepsy after kainate-induced status epilepticus. Epilepsia 2010, 51, 371-383.
35. Loscher, W. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res. 2002, 50, 105-123.
36. Reddy, D.S.; Gangisetty, O.; Briyal, S. Disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis. Neuropharmacology 2010, 59, 573-581.
37. Reddy, D.S.; Kuruba, R.; Wu, X. Comparative Characterization of Organophosphate-intoxication and Lithium-pilocarpine Models of Refractory Status Epilepticus and Neurodegeneration. In Proceedings of the 4th Biennial North American Epilepsy Congress, American Epilepsy Society, San Diego, December 2-6, 2012; AES Annual Meeting Abstract 2.028.
38. Goodman, J.H. Experimental Models of Status Epilepticus. In Neuropharmacology Methods in Epilepsy Research; CRB Press LLC: New York, NY, USA, 1998; pp. 95-125.
39. Reddy, D.S.; Mohan, A. Development and persistence of limbic epileptogenesis are impaired in mice lacking progesterone receptors. J. Neurosci. 2011, 31, 650-658.
40. Galanopoulou, A.S.; Buckmaster, P.S.; Staley, K.J.; Moshé, S.L.; Perucca, E.; Engel, J., Jr.; Löscher, W.; Noebels, J.L.; Pitkänen, A.; Stables, J.; White, H.S.; et al. Identification of new epilepsy treatments: Issues in preclinical methodology. Epilepsia 2012, 53, 571-582.
41. Sloviter, R.S. Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy. Science 1987, 235, 73-76.
42. Tilelli, C.Q.; Del Vecchio, F.; Fernandes, A.; Garcia-Cairasco, N. Different types of status epilepticus lead to different levels of brain damage in rats. Epilepsy Behav. 2005, 7, 401-410.
43. Lothman, E.W.; Collins, R.C. Kainic acid induced limbic seizures: Metabolic, behavioral, electroencephalographic and neuropathological correlates. Brain Res. 1981, 218, 299-318.
44. Vicedomini, J.P.; Nadler, J.V. A model of status epilepticus based on electrical stimulation of hippocampal afferent pathways. Exp. Neurol. 1987, 96, 681-691.
45. Lothman, E.W.; Bertram, E.H.; Bekenstein, J.W.; Perlin, J.B. Self-sustaining limbic status epilepticus induced by 'continuous' hippocampal stimulation: Electrographic and behavioral characteristics. Epilepsy Res. 1989, 3, 107-119.
46. McIntyre, D.C.; Stokes, K.A.; Edson, N. Status epilepticus following stimulation of a kindled hippocampal focus in intact and commissurotomized rats. Exp. Neurol. 1986, 94, 554-570.
47. Ben-Ari, Y.; Tremblay, E.; Riche, D.; Ghilini, G.; Naquet, R. Electrographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculline or pentetrazole: Metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy. Neuroscience 1981, 6, 1361-1391.
48. Scerrati, M.; Onofrj, M.; Pacifici, L.; Pola, P.; Ramacci, M.T.; Rossi, G.F. Electrocerebral and behavioural analysis of systemic kainic acid-induced epilepsy in the rat. Drugs Exp. Clin. Res. 1986, 12, 671-680.
49. Sperk, G. Kainic acid seizures in the rat. Prog. Neurobiol. 1994, 42, 1-32.
50. Sperk, G.; Lassmann, H.; Baran, H.; Kish, S.J.; Seitelberger, F.; Hornykiewicz, O. Kainic acid induced seizures: Neurochemical and histopathological changes. Neuroscience 1983, 10, 1301-1315.
51. Sperk, G.; Lassmann, H.; Baran, H.; Seitelberger, F.; Hornykiewicz, O. Kainic acid-induced seizures: Dose-relationship of behavioural, neurochemical and histopathological changes. Brain Res. 1985, 338, 289-295.
52. Sutula, T.; Harrison, C.; Steward, O. Chronic epileptogenesis induced by kindling of the entorhinal cortex: The role of the dentate gyrus. Brain Res. 1986, 385, 291-299.
53. Turski, W.A.; Cavalheiro, E.A.; Bortolotto, Z.A.; Mello, L.M.; Schwarz, M.; Turski, L. Seizures produced by pilocarpine in mice: A behavioral, electroencephalographic and morphological analysis. Brain Res. 1984, 321, 237-253.
54. Turski, L.; Cavalheiro, E.A.; Sieklucka-Dziuba, M.; Ikonomidou-Turski, C.; Czuczwar, S.J.; Turski, W.A. Seizures produced by pilocarpine: Neuropathological sequelae and activity of glutamate decarboxylase in the rat forebrain. Brain Res. 1986, 398, 37-48.
55. Turski, W.A.; Czuczwar, S.J.; Kleinrok, Z.; Schwarz, M.; Turski, L. Intraamygdaloid morphine produce.; seizures and brain damage in rats. Life Sci. 1983, 33, 615-618.
56. Turski, W.A.; Cavalheiro, E.A.; Turski, L.; Kleinrok, Z. Intrahippocampal bethanechol in rats: Behavioural, electroencephalographic and neuropathological correlates. Behav. Brain Res. 1983, 7, 361-370.
57. Turski, W.A.; Czuczwar, S.J.; Kleinrok, Z.; Turski, L. Cholinomimetics produce seizures and brain damage in rats. Experientia 1983, 39, 1408-1411.
58. Cavalheiro, E.A.; Silva, D.F.; Turski, W.A.; Calderazzo-Filho, L.S.; Bortolotto, Z.A.; Turski, L. The susceptibility of rats to pilocarpine-induced seizures is age-dependent. Brain Res. 1987, 465, 43-58.
59. Jope, R.S.; Morrisett, R.A. Neurochemical consequences of status epilepticus induced in rats by coadministration of lithium and pilocarpine. Exp. Neurol. 1986, 93, 404-414.
60. Morrisett, R.A.; Jope, R.S.; Snead, O.C. Effects of drugs on the initiation and maintenance of status epilepticus induced by administration of pilocarpine to lithium-pretreated rats. Exp. Neurol. 1987, 97, 193-200.
61. McDonough, J.H., Jr.; Dochterman, L.W.; Smith, C.D.; Shih, T.M. Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment. Neurotoxicology 1995, 16, 123-132.
62. Deshpande, L.S.; Carter, D.S.; Blair, R.E.; Delorenzo, R.J. Development of a prolonged calcium plateau in hippocampal neurons in rats surviving status epilepticus induced by the organophosphate diisopropylfluorophosphate. Toxicol. Sci. 2010, 116, 623-631.
63. Todorovic, M.S.; Cowan, M.L.; Balint, C.A.; Sun, C.; Kapur, J. Characterization of status epilepticus induced by two organophosphates in rats. Epilepsy Res. 2012, 101, 268-276.
64. Davis, W.M.; King, W.T. Pharmacogenetic factor in the convulsive responses of mice to flurothyl. Experientia 1967, 23, 214-215.
65. Wasterlain, C.G. Developmental brain damage after chemically induced epileptic seizures. Eur. Neurol. 1975, 3, 495-498.
66. Sperber, E.F.; Moshé, S.L. Age-related differences in seizure susceptibility to flurothyl. Dev. Brain Res. 1988, 39, 295-297.
67. Velíšková, J.; Velíšek, L.; Nunes, M.; Moshé, S. Developmental regulation of regional functionality of substantia nigra GABAA receptors involved in seizures. Eur. J. Pharmacol. 1996, 309, 167-173.
68. Walton, N.Y.; Treiman, D.M. Experimental secondarily generalized convulsive status epilepticus induced by D,L-homocysteine thiolactone. Epilepsy Res. 1988, 2, 79-86.
69. Dubé, C.; Chen, K.; Eghbal-Ahmadi, M.; Brunson, K.; Soltesz, I.; Baram, T.Z. Prolonged febrile seizures in the immature rat model enhance hippocampal excitability long term. Ann. Neurol. 2000, 47, 336-344.
70. Dubé, C.; Richichi, C.; Bender, R.A.; Chung, G.; Litt, B.; Baram, T.Z. Temporal lobe epilepsy after experimental prolonged febrile seizures: Prospective analysis. Brain 2006, 129, 911-922.
71. Dubé, C.; Vezzani, A.; Behrens, M.; Bartfai, T.; Baram, T.Z. Interleukin-1beta contributes to the generation of experimental febrile seizures. Ann. Neurol. 2005, 57, 152-155.
72. Dubé, C.M.; Ravizza, T.; Hamamura, M.; Zha, Q.; Keebaugh, A.; Fok, K.; Andres, A.L.; Nalcioglu, O.; Obenaus, A.; Vezzani, A.; et al. Epileptogenesis provoked by prolonged experimental febrile seizures: Mechanisms and biomarkers. J. Neurosci. 2010, 30, 7484-7494.
73. Baram, T.Z.; Gerth, A.; Schultz, L. Febrile seizures: An appropriate-aged model suitable for long-term studies. Dev. Brain. Res. 1997, 98, 265-270.
74. Dubé, C.; Yu, H.; Nalcioglu, O.; Baram, T.Z. Serial MRI after experimental febrile seizures: Altered T2 signal without neuronal death. Ann. Neurol. 2004, 56, 709-714.
75. Dreier, J.P.; Zhang, C.L.; Heinemann, U. Phenytoin, phenobarbital, and midazolam fail to stop status epilepticus-like activity induced by low magnesium in rat entorhinal slices, but can prevent its development. Acta Neurol. Scand. 1998, 98, 154-160.
76. Fueta, Y.; Kunugita, N.; Schwarz, W. Antiepileptic action induced by a combination of vigabatrin and tiagabine. Neuroscience 2005, 132, 335-345.
77. Pfeiffer, M.; Draguhn, A.; Meierkord, H.; Heinemann, U. Effects of gamma-aminobutyric acid (GABA) agonists and GABA uptake inhibitors on pharmacosensitive and pharmacoresistant epileptiform activity in vitro. Br. J. Pharmacol. 1996, 119, 569-577.
78. 2+ on synaptic and neural function in the CA1 region of the hippocampal slice. Brain Res. 1986, 377, 229-239.
79. Poolos, N.P.; Mauk, M.D.; Kocsis, J.D. Activity-evoked increases in extracellular potassium modulate presynaptic excitability in the CA1 region of the hippocampus. Neurophysiology 1987, 58, 404-416.
80. Poolos, N.P.; Kocsis, J.D. Elevated extracellular potassium concentration enhances synaptic activation of N-methyl-D-aspartate receptors in hippocampus. Brain Res. 1990, 508, 7-12.
81. Spyker, D.A.; Lynch, C.; Shabanowitz, J.; Sinn, J.A. Poisoning with 4-aminopyridine: Report of three cases. Clin. Toxicol. 1980, 16, 487-497.
82. Salazar, P.; Tapia, R.; Rogawski, M.A. Effects of neurosteroids on epileptiform activity induced by picrotoxin and 4-aminopyridine in the rat hippocampal slice. Epilepsy Res. 2003, 55, 71-82.
83. Reddy, D.S. Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3alpha-androstanediol and 17beta-estradiol. Neuroscience 2004, 129, 195-207.
84. Avoli, M.; Perreault, P.; Olivier, A.; Villemure, J.G. 4-Aminopyridine induces a long-lasting depolarizing GABA-ergic potential in human neocortical and hippocampal neurons maintained in vitro. Neurosci. Lett. 1988, 94, 327-332.
85. Gähwiler, B.H. Organotypic cultures of neural tissue. Trends Neurosci. 1988, 11, 484-489.
86. Stoppini, L.; Buchs, P.A.; Muller, D. A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods 1991, 37, 173-182.
87. Muller, D.; Buchs, P.A.; Stoppini, L. Time course of synaptic development in hippocampal organotypic cultures. Dev. Brain Res. 1993, 71, 93-100.
88. Buchs, P.A.; Stoppini, L.; Muller, D. Structural modifications associated with synaptic development in area CA1 of rat hippocampal organotypic cultures. Dev. Brain Res. 1993, 71, 81-91.
89. Gähwiler, B.H.; Capogna, M.; Debanne, D.; McKinney, R.A.; Thompson, S.M. Organotypic slice cultures: A technique has come of age. Trends Neurosci. 1997, 20, 471-477.
90. Martin, B.S.; Kapur, J. A combination of ketamine and diazepam synergistically controls refractory status epilepticus induced by cholinergic stimulation. Epilepsia 2008, 49, 248-255.
91. Glien, M.; Brandt, C.; Potschka, H.; Voigt, H.; Ebert, U.; Löscher, W. Repeated low-dose treatment of rats with pilocarpine: Low mortality but high proportion of rats developing epilepsy. Epilepsy Res. 2001, 46, 111-119.
92. Hellier, J.L.; Patrylo, J.R.; Buckmaster, P.S.; Dudek, F.E. Recurrent spontaneous motor seizures after repeated low-dose systemic treatment with kainate: Assessment of a rat model of temporal lobe epilepsy. Epilepsy Res. 1998, 31, 73-84.
93. Goodkin, H.P.; Kapur, J. The impact of diazepam's discovery on the treatment and understanding of status epilepticus. Epilepsia 2009, 50, 2011-2018.
94. Naylor, D.E.; Liu, H.; Wasterlain, C.G. Trafficking of GABA-A receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. J. Neurosci. 2005, 25, 7724-7733.
95. Kadriu, B.; Guidotti, A.; Costa, E.; Auta, J. Imidazenil, a nonsedating anticonvulsant benzodiazepine, is more potent than diazepam in protecting against DFP-induced seizures and neuronal damage. Toxicology 2009, 256, 164-174.
96. Li, Y.; Lein, P.J.; Liu, C.; Bruun, D.A.; Tewolde, T.; Ford, G.; Ford, B.D. Spatiotemporal pattern of neuronal injury induced by DFP in rats: A model for delayed neuronal cell death following acute OP intoxication. Toxicol. Appl. Pharmacol. 2011, 253, 261-269.
97. Sloviter, R.S. Feedforward and feedback inhibition of hippocampal principal cell activity evoked by perforant path stimulation: GABA-mediated mechanisms that regulate excitability in vivo. Hippocampus 1991, 1, 31-40.
98. Sloviter, R.S.; Dean, E.; Sollas, A.L.; Goodman, J.H. Apoptosis and necrosis induced in different hippocampal neuron populations by repetitive perforant path stimulation in the rat. J. Comp. Neurol. 1996, 366, 516-533.
99. Gorter, J.A.; Vliet, E.A.; Aronica, E.; Lopes da Silva, F.H. Progression of spontaneous seizures after van status epilepticus is associated with mossy fibre sprouting and extensive bilateral loss of hilar parvalbumin and somatostatin-immunoreactive neurons. Eur. J. Neurosci. 2001, 13, 657-669.
100. Mazarati, A.; Lu, X.; Shinmei, S.; Badie-Mahdavi, H.; Bartfai, T. Patterns of seizures, hippocampal injury and neurogenesis in three models of status epilepticus in galanin receptor type 1 (GalR1) knockout mice. Neuroscience 2004, 128, 431-441.
101. Ribak, C.E.; Tran, P.H.; Spigelman, I.; Okazaki, M.M.; Nadler, J.V. Status epilepticus-induced hilar basal dendrites on rodent granule cells contribute to recurrent excitatory circuitry. J. Comp. Neurol. 2000, 428, 240-253.
102. Schwob, J.E.; Fuller, T.; Price, J.L.; Olney, J.W. Widespread patterns of neuronal damage following systemic or intracerebral injections of kainic acid: A histological study. Neuroscience 1980, 5, 991-1014.
103. Bastlund, J.F.; Jennum, P.; Mohapel, P.; Penschuck, S.; Watson, W.P. Spontaneous epileptic rats show changes in sleep architecture and hypothalamic pathology. Epilepsia 2005, 46, 934-938.
104. Racine, R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 1972, 32, 281-294.
105. Vezzani, A.; Conti, M.; de Luigi, A.; Ravizza, T.; Moneta, D.; Marchesi, F; de Simoni, M.G. Interleukin-1β immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: Functional evidence for enhancement of electrographic seizures. J. Neurosci. 1999, 19, 5054-5065.
106. Cavazos, J.E.; Sutula, T.P. Progressive neuronal loss induced by kindling: A possible mechanism for mossy fiber synaptic reorganization and hippocampal sclerosis. Brain Res. 1990, 527, 1-6.
107. Brandt, C.; Glien, M.; Potschka, H.; Volk, H.; Loscher, W. Epileptogenesis and neuropathology after different types of status epilepticus induced by prolonged electrical stimulation of the basolateral amygdala in rats. Epilepsy Res. 2003, 55, 83-103.
108. Bertram, E.H.; Lothman, E.W. NMDA receptor antagonists and limbic status epilepticus: A comparison with standard anticonvulsants. Epilepsy Res. 1990, 5, 177-184.
109. Bertram, E.H.; Lothman, E.W.; Lenn, N.J. The hippocampus in experimental chronic epilepsy: A morphometric analysis. Ann. Neurol. 1990, 27, 43-48.
110. Lothman, E.W.; Bertram, E.H. Epileptogenic effects of status epilepticus. Epilepsia 1993, 34, S59-S70.
111. Lothman, E.W.; Bertram, E.H.; Kapur, J.; Stringer, J.L. Recurrent spontaneous hippocampal seizures in the rat as a chronic sequela to limbic status epilepticus. Epilepsy Res. 1990, 6, 110-118.
112. McIntyre, D.C.; Nathanson, D.; Edson, N. A new model of partial status epilepticus based on kindling. Brain Res. 1982, 250, 53-63.
113. Olney, J.W.; Rhee, V.; Ho, O.L. Kainic acid: A powerful neurotoxic analogue of glutamate. Brain Res. 1974, 77, 507-512.
114. Collingridge, G.L.; Lester, R.A. Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol. Rev. 1989, 41, 143-210.
115. Sutula, T.; Cascino, G.; Cavazos, J.; Parada, I.; Ramirez, L. Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann. Neurol. 1989, 26, 321-30.
116. Houser, C.R. Granule cell dispersion in the dentate gyrus of humans with temporal lobe epilepsy. Brain Res. 1990, 535, 195-204.
117. Tauck, D.L.; Nadler, J.V. Evidence of functional mossy fiber sprouting in hippocampal formation of kainic acid-treated rats. J. Neurosci. 1985, 5, 1016-1022.
118. Treiman, D.M. Efficacy and safety of antiepileptic drugs: A review of controlled trials. Epilepsia 1987, 28, S1-S8.
119. Kuruba, R.; Hattiangady, B.; Parihar, V.K.; Shuai, B.; Shetty, A.K. Differential susceptibility of interneurons expressing neuropeptide Y or parvalbumin in the aged hippocampus to acute seizure activity. PLoS One 2011, 6, e24493.
120. Hattiangady, B.; Kuruba, R.; Shetty, A.K. Acute seizures in old age leads to a greater loss of CA1 pyramidal neurons, an increased propensity for developing chronic TLE and a severe cognitive dysfunction. Aging Dis. 2011, 2, 1-17.
121. Loscher, W.; Schmidt, D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res. 1988, 2, 145-181.
122. Honchar, M.P.; Olney, J.W.; Sherman, W.R. Systemic cholinergic agents induce seizures and brain damage in lithium-treated rats. Science 1983, 220, 323-325.
123. Mello, L.E.; Covolan, L. Spontaneous seizures preferentially injure interneurons in the pilocarpine model of chronic spontaneous seizures. Epilepsy Res. 1996, 26, 123-129.
124. Covolan, L.; Mello, L.E. Temporal profile of neuronal injury following pilocarpine or kainic acid-induced status epilepticus. Epilepsy Res. 2000, 39, 133-152.
125. Covolan, L.; Ribeiro, L.T.; Longo, B.M.; Mello, L.E. Cell damage and neurogenesis in the dentate granule cell layer of adult rats after pilocarpine-or kainate-induced status epilepticus. Hippocampus 2000, 10, 169-180.
126. Buckmaster, P.S.; Zhang, G.F.; Yamawaki, R. Axon sprouting in a model of temporal lobe epilepsy creates a predominantly excitatory feedback circuit. J. Neurosci. 2002, 22, 6650-6658.
127. Mello, L.E.; Cavalheiro, E.A.; Tan, A.M.; Kupfer, W.R.; Pretorius, J.K.; Babb, T.L.; Finch, D.M. Circuit mechanisms of seizures in the pilocarpine model of chronic epilepsy: Cell loss and mossy fiber sprouting. Epilepsia 1993, 34, 985-995.
128. Babb, T.L.; Kupfer, W.R.; Pretorius, J.K.; Crandall, P.H.; Levesque, M.F. Synaptic reorganization by mossy fibers in human epileptic fascia dentata. Neuroscience 1991, 42, 351-363.
129. Buckmaster, P.S.; Haney, M.M. Factors affecting outcomes of pilocarpine treatment in a mouse model of temporal lobe epilepsy. Epilepsy Res. 2012, 102, 153-159.
130. Jope, R.S.; Morrisett, R.A.; Snead, O.C. Characterization of lithium potentiation of pilocarpine-induced status epilepticus in rats. Exp. Neurol. 1986, 91, 471-480.
131. Karalliedde, L.; Senanayake, N. Organophosphorus insecticide poisoning. Br. J. Anaesth. 1989, 63, 736-750.
132. Bajgar, J. Organophosphates/nerve agent poisoning: Mechanism of action, diagnosis, prophylaxis, and treatment. Adv. Clin. Chem. 2004, 38, 151-216.
133. Bouzarth, W.F.; Himwich, H.E. Mechanism of seizures induced by diisopropyl-flurophosphate (DFP). Am. J. Psychiatry 1952, 108, 847-855.
134. McDonough, J.H., Jr.; Shih, T.M. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci. Biobehav. Rev. 1997, 21, 559-579.
135. Shih, T.M.; Duniho, S.M.; McDonough, J.H. Control of nerve agent-induced seizures is critical for neuroprotection and survival. Toxicol. Appl. Pharmacol. 2003, 188, 69-80.
136. Lánský, P.; Velíšková, J.; Velíšek, L. An indirect method for absorption rate estimation: Flurothyl-induced seizures. Bull. Math. Biol. 1997, 59, 569-579.
137. Treiman, D.M. Generalized convulsive status epilepticus in the adult. Epilepsia 1993, 34, S2-S11.
138. Cendes, F. Febrile seizures and mesial temporal sclerosis. Curr. Opin. Neurol. 2004, 17, 161-164.
139. Shinnar, S.; Hesdorffer, D.C.; Nordli, D.R., Jr.; Pellock, J.M.; O'Dell, C.O.; Lewis, D.V.; Frank, L.M.; Moshé, S.L.; Epstein, L.G.; Marmarou, A.; et al. Phenomenology of prolonged febrile seizures: Results of the FEBSTAT study. Neurology 2008, 71, 170-176.
140. Heida, J.G.; Teskey, G.C.; Pittman, Q.J. Febrile convulsions induced by the combination of lipopolysaccharide and low-dose kainic acid enhance seizure susceptibility, not epileptogenesis, in rats. Epilepsia 2005, 46, 1898-1905.
141. Dudek, F.E.; Ekstrand, J.J.; Staley, K.J. Is neuronal death necessary for acquired epileptogenesis in the immature brain? Epilepsy Curr. 2010, 10, 95-99.
142. Galvan, M.; Grafe, P.; Bruggencate, G. Convulsant actions of 4-aminopyridine on the guinea-pig olfactory cortex slice. Brain Res. 1982, 241, 75-86.
143. Voskuyl, R.A.; Albus, H. Spontaneous epileptiform discharges in hippocampal slices induced by 4-aminopyridine. Brain Res. 1985, 342, 54-66.
144. Rutecki, P.A.; Lebeda, F.J.; Johnston, D. 4-Aminopyridine produces epileptiform activity in hippocampus and enhances synaptic excitation and inhibition. J. Neurophysiol. 1987, 57, 1911-1924.
145. Szente, M.; Baranyi, A. Mechanism of aminopyridine-induced ictal seizure activity in the cat neocortex. Brain Res. 1987, 413, 368-373.
146. 2+ induced epileptiform activity in rat temporal cortex slices. Exp. Brain Res. 1991, 87, 581-96.
147. Anderson, W.W.; Lewis, D.V.; Swartzwelder, H.S.; Wilson, W.A. Magnesium-free medium activates seizure-like events in the rat hippocampal slice. Brain Res. 1986, 398, 215-219.
148. Jones, R.S. Ictal epileptiform events induced by removal of extracellular magnesium in slices of entorhinal cortex are blocked by baclofen. Exp. Neurol. 1989, 104, 155-161.
149. Zhang, C.L.; Dreier, J.P.; Heinemann, U. Paroxysmal epileptiform discharges in temporal lobe slices after prolonged exposure to low magnesium are resistant to clinically used anticonvulsants. Epilepsy Res. 1995, 20, 105-111.
150. 2+ induced epileptiform activity from the rat entorhinal cortex to the hippocampus after kindling studied in vitro. Neurosci. Lett. 1996, 216, 41-44.
151. Chesnut, T.J.; Swann, J.W. Epileptiform activity induced by 4-aminopyridine in immature hippocampus. Epilepsy Res. 1988, 2, 187-195.
152. Perreault, P.; Avoli, M. Effects of low concentrations of 4-aminopyridine on CA1 pyramidal cells of the hippocampus. J. Neurophysiol. 1989, 61, 953-970.
153. Ferland, R.J.; Applegate, C.D. Decreased brainstem seizure thresholds and facilitated seizure propagation in mice exposed to repeated flurothyl-induced generalized forebrain seizures. Epilepsy Res. 1998, 30, 49-62.
154. Bausch, S.B.; McNamara, J.O. Synaptic connections from multiple subfields contribute to granule cell hyperexcitability in hippocampal slice cultures. J. Neurophysiol. 2000, 84, 2918-2932.
155. Berdichevsky, Y.; Sabolek, H.; Levine, J.B.; Staley, K.J.; Yarmush, M.L. Microfluidics and multielectrode array-compatible organotypic slice culture method. J. Neurosci. Methods 2009, 178, 59-64.
156. Dyhrfjeld-Johnsen, J.; Berdichevsky, Y.; Swiercz, W.; Sabolek, H.; Staley, K.J. Interictal spikes precede ictal discharges in an organotypic hippocampal slice culture model of epileptogenesis. J. Clin. Neurophysiol. 2010, 27, 418-424.
157. Järvelä, J.T.; Ruohonen, S.; Kukko-Lukjanov, T.K.; Plysjuk, A.; Lopez-Picon, F.R.; Holopainen, I.E. Kainic acid-induced neurodegeneration and activation of inflammatory processes in organotypic hippocampal slice cultures: Treatment with cyclooxygenase-2 inhibitor does not prevent neuronal death. Neuropharmacology 2011, 60, 1116-1125.
158. Tong, G.; Endersfelder, S.; Rosenthal, L.M.; Wollersheim, S.; Sauer, I.M.; Bührer, C.; Berger, F.; Schmitt, K.R. Effects of moderate and deep hypothermia on RNA-binding proteins RBM3 and CIRP expressions in murine hippocampal brain slices. Brain Res. 2013, 1504, 74-84.
159. Walton, N.Y.; Treiman, D.M. Response of status epilepticus induced by lithium and pilocarpine to treatment with diazepam. Exp. Neurol. 1988, 101, 267-275.
160. Wasterlain, C.G.; Chen, J.W. Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs. Epilepsia 2008, 49, 63-73.
161. Mazarati, A.M.; Baldwin, R.A.; Sankar, R.; Wasterlain, C.G. Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus. Brain Res. 1998, 814, 179-185.
162. Huang, L.Z.; Abbott, L.C.; Winzer-Serhan, U.H. Effects of chronic neonatal nicotine exposure on nicotinic acetylcholine receptor binding, cell death and morphology in hippocampus and cerebellum. Neuroscience 2007, 146, 1854-1868.
163. Schmued, L.C.; Albertson, C.; Slikker, W. Fluoro-Jade: A novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res. 1997, 751, 37-46.
164. Hopkins, K.J.; Wang, G.; Schmued, L.C. Temporal progression of kainic acid induced neuronal and myelin degeneration in the rat forebrain. Brain Res. 2000, 864, 69-80.
165. Zeng, L.H.; Rensing, N.R.; Wong, M. The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. J. Neurosci. 2009, 29, 6964-6972.
166. Kuruba, R.; Hattiangady, B.; Shetty, A.K. Hippocampal neurogenesis and neural stem cells in temporal lobe epilepsy. Epilepsy Behav. 2009, 14, 65-73.
167. Wojtowicz, J.M.; Kee, N. BrdU assay for neurogenesis in rodents. Nat. Protoc. 2006, 1, 1399-1405.
168. Parihar, V.K.; Hattiangady, B.; Kuruba, R.; Shuai, B.; Shetty, A.K. Predictable chronic mild stress improves mood, hippocampal neurogenesis and memory. Mol. Psychiatry 2009, 16, 171-183.
169. Kuruba, R.; Shetty, A.K. Could hippocampal neurogenesis be a future drug target for treating temporal lobe epilepsy? CNS Neurol. Disord. Drug Targets 2007, 6, 342-357.
170. Sloviter, R.S. A simplified Timm stain procedure compatible with formaldehyde fixation and routine paraffin embedding of rat brain. Brain Res. Bull. 1982, 8, 771-774.
171. Minami, M.; Kuraishi, Y.; Satoh, M. Effects of kainic acid on messenger RNA levels of IL-1β, IL-6, TNF-α and LIF in the rat brain. Biochem. Biophys. Res. Commun. 1991, 176, 593-598.
172. De Simoni, M.G.; Perego, C.; Ravizza, T.; Moneta, D.; Conti, M.; Marchesi, F.; de Luigi, A.; Garattini, S.; Vezzani, A. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur. J. Neurosci. 2000, 12, 2623-2633.
173. Vezzani, A.; Granata, T. Brain inflammation in epilepsy: Experimental and clinical evidence. Epilepsia 2005, 46, 1724-1743.
174. Turrin, N.P.; Rivest, S. Innate immune reaction in response to seizures: Implications for the neuropathology associated with epilepsy. Neurobiol. Dis. 2004, 16, 321-334.
175. Voutsinos-Porche, B.; Koning, E.; Kaplan, H.; Ferrandon, A.; Guenounou, M.; Nehlig, A.; Motte, J. Temporal patterns of the cerebral inflammatory response in the rat lithium-pilocarpine model of temporal lobe epilepsy. Neurobiol. Dis. 2004, 17, 385-402.
176. Librizzi, L.; Noè, F.; Vezzani, A.; de Curtis, M.; Ravizza, T. Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage. Ann Neurol. 2012, 72, 82-90.
177. He, J.; Evans, C.O.; Hoffman, S.W.; Oyesiku N.M.; Stein, D.G. Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury. Exp. Neurol. 2004, 189, 404-412.
178. VanLandingham, J.W.; Cekic, M.; Cutler, S.; Hoffman, S.W.; Stein, D.G. Neurosteroids reduce inflammation after TBI through CD55 induction. Neurosci. Lett. 2007, 425, 94-98.
179. White, S.H. Epilepsy and Disease Modification: Animal Models for Novel Drug Discovery. In Epilepsy: Mechanisms, Models, and Translatioal Perspectives; Rho, J.M., Sankar, R., Stafstrom, C.E., Eds.; CRS Press: New York, 2010; pp. 143-153.
180. Hellier, J.L.; Patrylo, J.R.; Dou, P.; Nett, M.; Rose, G.M.; Dudek, F.E. Assessment of inhibition and epileptiform activity in the septal dentate gyrus of freely behaving rats during the first week after kainate treatment. J. Neurosci. 1999, 19, 100053-100064.
181. Turski, W.A.; Cavalheiro, E.A.; Coimbra, C.; da Penha Berzaghi, M.; Ikonomidou-Turski, C.; Turski, L. Only certain antiepileptic drugs prevent seizures induced by pilocarpine. Brain Res. 1987, 434, 281-305.
182. Kadriu, B.; Guidotti, A.; Costa, E.; Davis, J.M.; Auta, J. Acute imidazenil treatment after the onset of DFP-induced seizure is more effective and longer lasting than midazolam at preventing seizure activity and brain neuropathology. Toxicol. Sci. 2011, 120, 136-145.